InvestorsHub Logo
icon url

misiu143

02/08/19 12:14 PM

#35501 RE: finesand #35500

I agree with you Finesand ,
And for a company treating HIV , cancers , GvHD and few more diseases 600 mil shares is not much at all
IMO


icon url

BlackDoggie

02/08/19 12:27 PM

#35505 RE: finesand #35500

100M shares at current terms would net closer to $30mm additional, after accounting for warrant coverage and broker fees. Still enough, but let's not overstate the headroom the company currently has. And if we're maxing out our A/S through private placements, we're probably not going to do it on significantly better terms than we currently are. Because... economics is a thing.

And regarding building a sales/distribution force... why not? I agree it's not ideal, but sales and distribution isn't rocket science. If they slow down R&D expenditures greatly in order to focus on near-revenue products, they could put together the cash (see above) to put together a small sales and distribution operation. I never said it would start as a full-scale, BP-esque roll out, and explicitly acknowledged that it would significantly impact predicted market penetration and timelines for further developments.

Working with a distributor on a limited basis may be easier, I'll grant that.